Candriam S.C.A. Bio N Tech Se Transaction History

Candriam S.C.A.

$16.3 Billion
Q2 2024

A detailed history of Candriam S.C.A. transactions in Bio N Tech Se stock. As of the latest transaction made, Candriam S.C.A. holds 578,998 shares of BNTX stock, worth $68.8 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

578,998

Previous 160,303 261.19%

Holding current value

$68.8 Million

Previous $14.8 Million 214.65%

% of portfolio

0.29%

Previous 0.1%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$80.36 - $102.87 $33.6 Million - $43.1 Million	418,695 Added 261.19%	578,998 $46.5 Million
Q1 2024 May 03, 2024	BUY	$88.96 - $112.35 $10.7 Million - $13.5 Million	120,000 Added 297.74%	160,303 $14.8 Million
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $1.82 Million - $2.26 Million	-20,000 Reduced 33.17%	40,303 $4.25 Million
Q3 2023 Nov 13, 2023	SELL	$98.5 - $125.08 $8.08 Million - $10.3 Million	-82,000 Reduced 57.62%	60,303 $6.55 Million
Q2 2023 Aug 08, 2023	SELL	$102.58 - $129.66 $1.03 Million - $1.31 Million	-10,080 Reduced 6.61%	142,303 $15.4 Million
Q4 2022 Feb 13, 2023	SELL	$118.43 - $186.05 $7.46 Million - $11.7 Million	-63,033 Reduced 29.26%	152,383 $22.9 Million
Q3 2022 Nov 10, 2022	SELL	$127.65 - $183.11 $2.9 Million - $4.16 Million	-22,718 Reduced 9.54%	215,416 $29.1 Million
Q2 2022 Aug 03, 2022	SELL	$123.25 - $186.24 $493,000 - $744,960	-4,000 Reduced 1.65%	238,134 $35.5 Million
Q1 2022 May 13, 2022	BUY	$126.25 - $231.85 $155,540 - $285,639	1,232 Added 0.51%	242,134 $41.3 Million
Q4 2021 Feb 10, 2022	BUY	$216.64 - $362.52 $27.7 Million - $46.3 Million	127,705 Added 112.82%	240,902 $61.6 Million
Q3 2021 Nov 09, 2021	BUY	$205.93 - $447.23 $1.87 Million - $4.07 Million	9,100 Added 8.74%	113,197 $30.9 Million
Q2 2021 Jul 20, 2021	BUY	$113.32 - $241.49 $1.85 Million - $3.94 Million	16,336 Added 18.61%	104,097 $23.3 Million
Q4 2020 Jan 22, 2021	SELL	$72.71 - $129.54 $18.9 Million - $33.7 Million	-259,776 Reduced 74.75%	87,761 $7.15 Million
Q3 2020 Oct 19, 2020	SELL	$57.81 - $104.17 $3.63 Million - $6.54 Million	-62,776 Reduced 15.3%	347,537 $24.1 Million
Q2 2020 Jul 23, 2020	BUY	$38.58 - $66.74 $15.8 Million - $27.4 Million	410,313 New	410,313 $27.4 Million

Others Institutions Holding BNTX

# of Institutions

328

Shares Held

40.6M

Call Options Held

845K

Put Options Held

1.23M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account